Open dvribeira opened 9 months ago
The biggest problem seems to be the effective[x] element. At first I can identify the following approaches:
The first option would better align how we use our resources with FHIR. This in itself would be a good idea. However it implies the biggest effort on all involved parties. The second option would effectively solve the problem with minimum effort.
With the preparation of the swiss IG of the International Patient Summary, there are some issues that should be identified in order for getting the PMP ready for this.
In principle, I see no use in providing other resources than the PMLC medication statements for the summary, hence it should be enough to be sure that at least these resources are compatible. Obviously other infrastructure resources like Patient an so on will also have to be checked.
For now, the CH IPS profile medication statement's structure imposes only cardinality constraints on making the medication and the subject mandatory. That's all right.
CH IPS medication statement profile also imposes conformance with FHIR's MedicationStatementIPS. After a fast look this might pose issues with several elements: